Anti-AgingFDA Approved
SS-31
Elamipretide
A mitochondria-targeted peptide that improves cellular energy production. FDA approved for Barth syndrome in September 2025.
FDA Approved40 mg subcutaneous daily
Peptide Database
Browse Research Peptides
Comprehensive profiles for 105+ peptides — dosing protocols, mechanisms of action, clinical research, and safety data.
105
Peptides
9
Categories
32 peptides match your filters · page 2 of 2
Weight LossFDA Approved
Semaglutide
Ozempic
A GLP-1 receptor agonist with multiple FDA approvals including weight management, type 2 diabetes treatment, cardiovascular risk reduction, and kidney disease protection. 94% amino acid similarity to human GLP-1.
FDA Approved1-2.4 mg weekly (after titration)
Weight LossFDA Approved
Semaglutide Oral
Rybelsus
The first oral GLP-1 receptor agonist FDA approved, using SNAC absorption enhancer. Achieves 80% bioavailability of subcutaneous injection.
FDA Approved3-14 mg daily (titrate up)
Weight LossFDA Approved
Setmelanotide
Imcivree
An MC4R agonist for rare genetic obesity disorders. FDA approved for specific gene mutations causing obesity.
FDA Approved2-3 mg daily
HormonalFDA Approved
Teriparatide
Forteo
A recombinant parathyroid hormone fragment that stimulates bone formation. Demonstrated 65% reduction in vertebral fractures in clinical trials.
FDA Approved20 mcg daily
Growth HormoneFDA Approved
Tesamorelin
Egrifta
An FDA-approved GHRH analog used to reduce excess abdominal fat in HIV-infected patients with lipodystrophy.
FDA Approved2 mg daily (F8: 1.28 mg daily)
Weight LossFDA Approved
Tirzepatide
Mounjaro
A dual GIP/GLP-1 receptor agonist representing next-generation incretin-based therapy, demonstrating superior weight loss outcomes compared to semaglutide in direct clinical comparisons.
FDA Approved5-15 mg weekly (after titration)
HealingFDA Approved
Ziconotide
Prialt
A synthetic cone snail venom peptide for severe chronic pain. The first intrathecal non-opioid analgesic FDA approved.
FDA ApprovedVia intrathecal pump (individualized)